Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
The synapse has consistently been considered a vulnerable and critical target within Alzheimer’s disease, and synapse loss is, to date, one of the main biological correlates of cognitive decline within Alzheimer’s disease. This occurs prior to neuronal loss with ample evidence that synaptic dysfunct...
Main Authors: | Soraya Meftah, Jian Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Synaptic Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnsyn.2023.1129036/full |
Similar Items
-
GSK3 and Alzheimer's disease: facts & fiction …
by: Fred eVanleuven
Published: (2011-08-01) -
Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01) -
Expanding the repertoire of biomarkers for Alzheimer’s disease: targeted and non-targeted approaches.
by: Douglas eGalasko
Published: (2015-12-01) -
Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
by: Anushka Chakravorty, et al.
Published: (2019-11-01) -
Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
by: Sonja Prpar Mihevc, et al.
Published: (2019-06-01)